Browsing by Author "Mahfouz, Ahmed"
Now showing items 1-19 of 19
-
A 5-year trend in the use of sodium-glucose co-transporter 2 inhibitors and other oral antidiabetic drugs in a Middle Eastern country
( Springer Science and Business Media Deutschland GmbH , 2022 , Article)Background: Sodium glucose co-transporter 2 inhibitors (SGLT2is) are a novel class of oral antidiabetic drugs. To date, there are no pharmacoepidemiologic studies investigating the pattern of use of SGLT2is compared to ... -
Adapting Smart Street Strategy for Post-Covid Built Environment
( Qatar University Press , 2023 , Conference)The street networks occupy 25% of land use and are the veins of cities. By 2050, more than two-thirds of the world’s population will live in urban areas. The urban street infrastructures and systems are expected to serve ... -
Adding colchicine to tocilizumab in hospitalized patients with severe COVID-19 pneumonia: An open-label randomized controlled trial
( Lippincott Williams and Wilkins , 2022 , Article)Introduction: Colchicine acts upstream in the cytokines cascade by inhibiting the nod-like receptor protein 3 (NLRP3) inflammasome while interleukin 6 (IL-6) receptor antagonists, such as tocilizumab, block the end result ... -
Association of single nucleotide polymorphisms with dyslipidemia and risk of metabolic disorders in the State of Qatar
( Wiley-Blackwell , 2023 , Article)Background: Dyslipidemia is recognized as one of the risk factors of cardiovascular diseases (CVDs), type 2 diabetes mellitus (T2DM), and non-alcoholic fatty liver disease (NAFLD). Objective: The study aimed to investigate ... -
Bridging vs Non-Bridging with Warfarin Peri-Procedural Management: Cost and Cost-Effectiveness Analyses
( Elsevier , 2021 , Article)The warfarin peri-procedural management in Qatar is predominantly based on bridging (63%), compared to non-bridging. This study sought to perform a first-time cost analysis of current warfarin peri-procedural management ... -
Clinical outcomes of high-intensity doses of atorvastatin in patients with acute coronary syndrome: A retrospective cohort study using real-world data
( Blackwell Publishing Ltd , 2021 , Article)Aims: To compare the effectiveness and safety of 2 high-intensity atorvastatin doses (40 mg vs 80 mg) among acute coronary syndrome (ACS) patients. Methods: This retrospective observational cohort study using real-world ... -
A Comparative Study of High-intensity Rosuvastatin Versus Atorvastatin Therapy Post-acute Coronary Syndrome Using Real-world Data
( Elsevier , 2021 , Article)A high-intensity statin is recommended for the secondary prevention of cardiovascular diseases (CVD). However, real-world evidence of the effectiveness of rosuvastatin following acute coronary syndrome (ACS) is scarce. ... -
Corrigendum: Sodium-glucose cotransporter-2 inhibitors improve cardiovascular outcomes post-acute coronary syndrome complicated by acute heart failure (Frontiers in Cardiovascular Medicine, (2024), 11, (1383669), 10.3389/fcvm.2024.1383669)
( Frontiers Media SA , 2025 , Article)In the published article, there was an error in the Funding statement. The authors declared receiving no financial support for the research, authorship, or publication of this article. The correct Funding statement appears ... -
Description of clinical pharmacists reported interventions to prevent adverse drug events among patients with cardiovascular disease in Qatar
(2024 , Article)Background: Unidentified drug-related problems (DRPs) can cause negative health and economic consequences if not addressed appropriately. The literature revealed that interventions conducted by clinical pharmacists can ... -
Efficacy and cost effectiveness of intravenous ferric carboxymaltose versus iron sucrose in adult patients with iron deficiency anaemia
( Public Library of Science , 2021 , Article)Background Iron deficiency anaemia (IDA) is a major health issues and common type of nutritional deficiency worldwide. For IDA treatment, intravenous (IV) iron is a useful therapy. Objective To determine the efficacy and ... -
Evaluating the appropriateness and the factors associated with sodium-glucose co-transporter 2 inhibitors prescribing in a Middle Eastern country: a cross-sectional study
( Springer Science and Business Media Deutschland GmbH , 2025 , Article)Background: Sodium glucose co-transporter 2 inhibitors (SGLT2is) are a novel class of oral antidiabetic drugs (ADDs). Studies evaluating the appropriateness of SGLT2is prescribing, and the factors associated with their ... -
Evaluation of Health Literacy Levels and Associated Factors Among Patients with Acute Coronary Syndrome and Heart Failure in Qatar
( Dove Press , 2023 , Article)Purpose: To determine the prevalence of inadequate health literacy and its associated risk factors among patients with acute coronary syndrome (ACS) and/or heart failure (HF) in Qatar. Patients and Methods: This cross-sectional ... -
Impact of Clinical Pharmacist Interventions on Economic Outcomes in a Cardiology Setting in Qatar
( Elsevier , 2023 , Article)We sought to investigate the economic impact of preventing adverse events in a cardiology setting in Qatar as an effect of the clinical pharmacist as an intervention. This is a retrospective study of interventions by ... -
Investigating physicians' views on non-formulary prescribing: a qualitative study using the theoretical domains framework
( Springer Science and Business Media Deutschland GmbH , 2023 , Article)Background: Well-designed and well-maintained drug formularies serve as a reliable resource to guide prescribing decisions; they are associated with improved medicine safety and increased efficiency, while also serving as ... -
Marketing Strategies for Smart Buildings
( Qatar University Press , 2023 , Conference)Globally, there is a growing proportion of the need to optimize monitoring and facility management of new and existing built facilities. Smart buildings provide waste reduction to the environment, flexibility to facility ... -
Proton pump inhibitor co-prescription with dual antiplatelet therapy among patients with acute coronary syndrome in Qatar
( Springer Netherlands , 2016 , Article)Background There are increasing concerns about clinically significant interactions between proton pump inhibitors (PPIs) and clopidogrel, resulting in adverse cardiovascular outcomes in patients with acute coronary syndromes ... -
Sodium-glucose cotransporter-2 inhibitors improve cardiovascular outcomes post-acute coronary syndrome complicated by acute heart failure
( Frontiers Media SA , 2024 , Article)Background: Acute coronary syndrome (ACS) remains a risk factor for heart failure (HF). Therefore, we aimed to assess the cardioprotective role of sodium–glucose cotransporter-2 (SGLT2) inhibitors post-ACS in patients with ... -
Trends in prescribing and outcomes in obese versus non-obese patients receiving rivaroxaban therapy: an observational study using real-world data
( Springer Science and Business Media Deutschland GmbH , 2023 , Article)Purpose To investigate real-world prescribing trends and clinical outcomes based on body mass index (BMI) categorization in patients who received rivaroxaban therapy. Methods This was a retrospective cohort study ... -
Trends of use of SGLT2 inhibitors in Qatar
( Qatar University Press , 2021 , Poster)Background: Type 2 diabetes mellitus (T2DM) represents a growing health challenge in Qatar and worldwide. T2DM is associated with a high risk of cardiovascular (CV) morbidity and mortality, and progression of renal disease. ...
